ScholarWorks@Korea University: Na, Jin Oh

Detailed Information

Na, Jin Oh (나진오)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 02-2626-3025
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Coronary artery spasm:7||atrial fibrillation:6||coronary artery spasm:6||Acetylcholine:6||Percutaneous coronary intervention:5||Acute myocardial infarction:5||catheter ablation:5||Atrial fibrillation:5||acetylcholine:4||Drugeluting stent:4||Clinical outcomes:4||Coronary artery disease:4||percutaneous coronary intervention:4||coronary artery disease:4||Echocardiography:4||Cardiovascular diseases:3||Type 2 Diabetes:3||hypertension:3||chronic total occlusion:3||angina:3||Heart failure:3||Diabetes mellitus:2||drugeluting stent:2||diabetes mellitus:2||left atrium:2||Critical limb ischemia:2||Antiplatelet therapy:2||Korea:2||outcomes:2||risk factors:2||Vasospastic angina:2||Risk factors:2||lipoprotein(a):2||endothelial dysfunction:2||pregnancy:2||myocardial infarction:2||Cholesterol:2||Acetylcholine provocation test:2||Chest pain:2||Creactive protein:2||computed tomography:2||Myocardial bridge:2||medical therapy:2||Newonset diabetes mellitus:2||coronary angiography:2||safety:2||sleep quality:1||meloxicam:1||Peripheral artery disease:1||intracoronary acetylcholine provocation test:1||carvedilol:1||Left main coronary artery:1||atrial function:1||Cigarette smoking:1||angiotensin converting enzyme inhibitor:1||Atherosclerosis:1||unstable plaque:1||preoperative care/methods:1||recurrence:1||peripheral transluminal angioplasty:1||central blood pressure:1||ASSOCIATION:1||Crista terminalis:1||Achinduced coronary vasospasm:1||Psychiatric status rating scales:1||coronary artery disease/prevention & control/therapy:1||peripheral arterial disease:1||handgrip:1||odds ratio:1||Sodiumglucose cotransporter2 inhibitors:1||Cardiovascular risk:1||COVID19 vaccine:1||Drugeluting stents:1||Atorvastatin:1||Telephone:1||statin responsiveness:1||Pericardium:1||Adipose tissue:1||parity:1||outcome:1||Chronic total occlusion:1||prediabetes:1||hyperuricaemia:1||heart failure:1||Clinical followup:1||nonselective ssblockers:1||bisoprolol:1||Drug eluting stents:1||angiotensin receptor blocker:1||arterial inflammation:1||coronary:1||PTA:1||Guideline:1||Skeletal muscle mass:1||Visceral adiposity:1||Left ventricular mass:1||body mass index:1||StentBoost:1||MYOCARDIALINFARCTION:1||Aortic calcification:1||PRASUGREL:1||hyperlipidemias/prevention & control:1||arteriosclerosis/blood:1||biological markers/blood:1||chirality:1||essential hypertension:1||sudden cardiac death:1||mortality:1||Cardiovascular death:1||Anticoagulant therapy:1||Vasoconstriction:1||Rosuvastatin:1||nonsteroidal antiinflammatory drugs:1||Health surveys:1||insulin resistance:1||cardiomyopathies:1||Alcohol:1||selective ss 1blockers:1||clinical followup:1||diabetic:1||Atrial septum:1||atrial function, left/physiology:1||stents:1||Major clinical outcomes:1||Magnetic resonance imaging:1||Tetralogy of Fallot:1||Linear ablation:1||body composition:1||index of microvascular resistance:1||pulse wave analysis:1||Cardiac CT:1||Hypertension:1||CLOPIDOGREL:1||cytokines:1||epicardial adipose tissue:1||inflammatory:1||Left atrial function:1||Antilipemic agents/therapeutic use:1||Noncardiac surgery:1||stroke:1||risk stratification:1||Empagliflozin:1||Diastolic:1||Prognosis:1||Computed tomography angiography:1||diastolic dysfunction:1||Diabetes:1||Intravascular ultrasound:1||epicardial fat:1||Heart atria:1||heart atria/pathology/ultrasonography:1||Epidemiology:1||Positron emission tomography:1||Angina pectoris, variant:1||valsalva sinus aneurysm:1||PROGNOSIS:1||Computed tomography:1||Mean platelet volume:1||sleep:1||Thromboembolic risk:1||Modified selfcontrolled caseseries:1||Combination:1||sleep disorders:1||antithrombotic therapy:1||cardiorespiratory fitness:1||statin:1||disease progression:1||Hemoglobin A1c:1||Angina:1||newonset diabetes mellitus:1||Coronary artery stenosis:1||coronary vasospasm:1||Clinical outcome:1||vasospasm:1||Heart:1||Coronary artery:1||Atrial mass:1||Plaque rupture:1||Acute coronary syndromes:1||Carotid arteries:1||Catheter ablation:1||Myocardial injury:1||Neutrophil/lymphocyte ratio:1||extracellular fluid:1||coronary microvascular function:1||aorta:1||coronary computed tomographic angiography:1||Percutaneous transluminal coronary angioplasty:1||endothelial function:1||Vascular endothelium:1||Coronary disease:1||lipoproteins, LDL/blood/chemistry:1||blood pressure monitoring:1||Samlodipine:1||6minute walk test:1||Dapagliflozin:1||Irbesartan/amlodipine:1||24&#8208:1||hour Holter study:1||Cilostazol:1||Awareness:1||dyslipidemia:1||Angina pectoris:1||Endovascular therapy:1||Multidetector computed tomography:1||left ventricular hypertrophy:1||air pollution:1||collateral circulation:1||left atrial function:1||multivessel disease:1||major adverse cardiac events:1||Atrial remodeling:1||Peripheral arterial disease:1||cardiac volume:1||restenosis:1||Evidencebased medicine:1||Arteriovenous fistula:1||Complex fractionated atrial electrograms:1||Insulin resistance:1||angioscopy:1||Acetylcholine dose:1||CARDIOVASCULAR MORTALITY:1||MAJOR DEPRESSION:1||UNSTABLE ANGINA:1||Aspirin:1||Function:1||Complications:1||Atrial septal aneurysm:1||ambulatory:1||coronary heart disease:1||(V)over doto(2max):1||Atrial flutter:1||Mitral regurgitation:1||Doppler:1||validation studies:1||Percutaneous transluminal angioplasty:1||Sex:1||lowdensity lipoprotein cholesterol:1||left ventricle:1||peripartum period:1||clinical outcomes:1||Diltiazem:1||nitrate:1||reninangiotensin system:1||acute coronary syndrome:1||PET/CT:1||Peripheral angiography:1||Atrial fibrillation/physiopathology:1||tomography, Xray computed/methods:1||Appropriateness criteria:1||blood sugar control:1||Inflammation:1||Ablation time:1||SYMPTOMS:1||Left atrium:1||Coronary calcification:1||multivessel coronary artery spasm:1||Valsartan:1||inflammation:1||lipids:1||exercise capacity:1||followup:1||recovery of function:1||left ventricular systolic dysfunction:1||in Korean adults:1||Endothelium:1||Cardiovascular outcome:1||cardiopulmonary coupling analysis:1||celecoxib:1||Sex characteristics:1||uric acid:1||sex differences:1||Gastroesophageal reflux:1||predictive value of tests:1||ROC curve:1||amputation:1||critical limb ischemia:1||Diastole:1||augmentation index:1||CORONARYHEARTDISEASE:1||FAILURE PATIENTS:1||RISK:1||Cryptogenic stroke:1||Right atrial mass.:1||Depression:1||particle size:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||cerebral infarction:1||electrocardiography:1||Dyslipidemias:1||LDL:1||Essential hypertension:1||Statin intensity:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE